Categories: BrainNews

Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

AUSTIN, Texas, Sept. 03, 2024 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage biotechnology company focused on Alzheimer’s disease, announced today that it has been invited to present at the H.C. Wainwright 26th Annual Global Investment Conference, being held in New York.

Rick Barry, Cassava’s Executive Chairman, will join in a ‘fireside chat’ with Vernon T. Bernardino, PhD., Managing Director, Biotechnology Equity Research, at H.C. Wainwright.

Institutional investors who are registered for this conference may log into www.hcwevents.com to request a meeting with Cassava Sciences, pending availability.

Event details follow:

Date: Monday, September 9th
Time: 3:00pm to 3:30 Eastern Time
Webcast: https://journey.ct.events/view/d574c934-b104-45ac-bf42-07f169ce0d11
   

A live webcast will be available on the “Investors” page of Cassava Sciences’ website, www.CassavaSciences.com. An archived replay will be available for 90 days following the event.

About Cassava Sciences, Inc.

Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Our novel science is based on stabilizing—but not removing—a critical protein in the brain.

For More Information Contact:
Eric Schoen, Chief Financial Officer
(512) 501-2450 or ESchoen@CassavaSciences.com

Staff

Recent Posts

EmpiRx Health Launches New Clinical Review Messaging Solution

New Text Notification Solution Strengthens the Pharmacy Care User Experience by Keeping Members Informed in…

3 hours ago

Kalorama Forecasts $2.3 Billion HbA1c Market by 2029, Driven by POC Growth, Emerging Markets, and Digital Innovation

ARLINGTON, Va., June 4, 2025 /PRNewswire/ -- Kalorama Information, a leading publisher of healthcare market…

3 hours ago

Elsevier Unveils Rigorous Evaluation Framework to Mitigate Risk in Generative AI Clinical Decision Support Tools

Clinician-centered framework will be featured in upcoming issue of the Open Access Journal of the…

3 hours ago

Grand Jury: City Needs to Buck Up Nonprofits and Get Out of Its Own Way to Better Help Vulnerable San Franciscans

2024–2025 San Francisco Civil Grand Jury Report calls out obstacles to effective social services grantmaking.…

3 hours ago

CIHI and GEMINI team up to modernize hospital data and improve patient care

TORONTO, June 4, 2025 /CNW/ - The Canadian Institute for Health Information (CIHI) and Unity…

3 hours ago